# ACT Venture Partners

> ACT Venture Partners is a VC fund backing Software. See 42 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Amsterdam, The Netherlands
- Total investments: 42
- Last investment: Jul 2026
- Lead investor: 69%
- Fund size: $29M
- Last fund: Jul 2015
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/act-venture-partners
- X (Twitter): https://www.twitter.com/act_vc
- Website: http://www.act-vc.com

ACT Venture Partners (ACT VP) is a venture capital firm that invests in early-stage deep-tech startups. ACT VP invested in 25 startups in total. ACT's investment philosophy is to identify early-stage ventures and back technical founders with visions and abilities to transform a market or an industry. ACT's target entrepreneurs developbreakthrough products and technologies, establish new market footholds or pursue novel business models.

## Contacts

5 contacts available for ACT Venture Partners. Shizune tracks 6 team members at ACT Venture Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/act-venture-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $345k–$3.2M |
| Series A | $2.4M–$9.5M |
| Convertible Note | $987k–$1.3M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 6 | 14% |
| Artificial Intelligence | 6 | 14% |
| Biotechnology | 4 | 10% |
| Manufacturing | 4 | 10% |
| Enterprise Software | 4 | 10% |

69 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 22 | 52% |
| Series A | 5 | 12% |
| Convertible Note | 4 | 10% |
| Pre-Seed | 2 | 5% |
| Venture - Series Unknown | 2 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Turkey | 10 | 24% |
| United States | 7 | 17% |
| United Kingdom | 4 | 10% |
| Spain | 1 | 2% |
| Canada | 1 | 2% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Duy Louis Tran | Investment Analyst | 0 | https://shizune.co/investors/profile/duy-tran-0047 |
| Erhan Z. Kilicozlu | Managing Partner | 1 | https://shizune.co/investors/profile/erhan-kilicozlu |
| Gokhan Guner | Managing Partner | 6 | https://shizune.co/investors/profile/gokhan-guner |
| Gozde Baloglu | Associate | 0 | https://shizune.co/investors/profile/gozde-baloglu |
| Gurcan Ozan | Partner | 2 | https://shizune.co/investors/profile/gurcan-ozan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NxLite | 3E Nano has developed and is commercializing a low cost, thermally and optically smart, Diamond-Like Carbon (DLC) coating. This nano thin film applied to glass and other transparent media is targeted toward windows, windshields, greenhouses, and solar module manufacturers. | $3.9M | Series A | Jul 16, 2026 |  |
| Cellbricks Therapeutics | Cellbricks offers plastic surgery and transplant medicine that rely on artificial materials devoid of physiological functions or immunosuppressive transplants from human and animal sources. It offers the bio-fabrication of human tissue and organs, a widespread medical procedure that enables people to live longer and in better condition. | $8.1M | Seed | Mar 25, 2026 |  |
| Qubitrium | Qubitrium develops advanced quantum technologies on the verge of the second quantum revolution. | $2.6M | Seed | Dec 21, 2025 |  |
| Aibuild | Aibuild is a software company with locations in London and Silicon Valley, that is transforming the Additive Manufacturing industry on a global scale. We are on a mission to make manufacturing efficient by accelerating the transition towards factories of the future that are cloud-connected, autonomous and primarily additive. |  |  | Dec 16, 2025 |  |
| NxLite | 3E Nano has developed and is commercializing a low cost, thermally and optically smart, Diamond-Like Carbon (DLC) coating. This nano thin film applied to glass and other transparent media is targeted toward windows, windshields, greenhouses, and solar module manufacturers. | $9.5M | Series A | Oct 14, 2025 |  |
| Qubitrium | Qubitrium develops advanced quantum technologies on the verge of the second quantum revolution. | $1.7M | Seed | Sep 05, 2024 |  |
| Meddenovo Drug Design | Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides. Our innovative approach leverages a unique blend of AI technologies and molecular modeling to significantly enhance the efficiency and success rates of drug development processes. Cyclic peptidesrepresent a groundbreaking class of compounds in pharmaceutical research. These molecules combine the best attributes of small molecules and large biologics, offering exceptional binding affinities, stability, and specificity. At Meddenovo, we are leaders in harnessing the potential of cyclic peptides, developing tailored solutions that push the boundaries of traditional drug discovery. Beyond small organic molecules, our expertise extends to peptide-based medicines and metal chelators, giving us a competitive edge in novel drug research and development. We excel in creating unique chemical spaces tailored to your needs and provide custom computational solutions for predicting drug resistance, elucidating biochemical reaction mechanisms, and conducting metal affinity analysis. At Meddenovo, we are dedicated to precision and reliability in drug discovery. Our approach reduces failure rates and improves outcomes, accelerating the journey from research to market. Our mission is to empower scientists worldwide with advanced, user-friendly AI tools, democratizing access to cutting-edge drug discovery technologies. | $1.1M | Pre-Seed | Jul 31, 2024 |  |
| Nextmol | Nextmol is a Barcelona-based startup specialized in computational chemistry. It develops a software platform to accelerate the design of new chemicals through molecular modeling and artificial intelligence for a more efficient R&D. Nextmol shortens the path to chemical innovation over the traditional lab approach thanks to its ability toperform unlimited testing via computations. Furthermore, computations provide key insights about the physico-chemical behavior of the candidate molecules. Nextmol is a spin-off company of the Barcelona Supercomputing Center, one of the largest supercomputing facilities in Europe. |  | Venture - Series Unknown | May 27, 2024 |  |
| Cellbricks Therapeutics | Cellbricks offers plastic surgery and transplant medicine that rely on artificial materials devoid of physiological functions or immunosuppressive transplants from human and animal sources. It offers the bio-fabrication of human tissue and organs, a widespread medical procedure that enables people to live longer and in better condition. |  | Venture - Series Unknown | Apr 23, 2024 |  |
| Rototip | Rototip is a manufacturing Marketplace. | $1.1M | Seed | Feb 26, 2024 |  |

10 of 42 investments shown.

## Co-investors
- [Earth Foundry](https://shizune.co/investors/profile/earthfoundry) — VC Fund, 3 deals together
- [New Climate Ventures](https://shizune.co/investors/profile/new-climate-ventures) — VC Fund, 3 deals together
- [500 Istanbul](https://shizune.co/investors/profile/500-istanbul) — VC Fund, 2 deals together
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 2 deals together
- [Atlas Ventures](https://shizune.co/investors/profile/atlas-ventures-67bb) — VC Fund, 2 deals together
- [Crabtree Lane Alt](https://shizune.co/investors/profile/crabtree-lane-alt) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [BITKRAFT Ventures](https://shizune.co/investors/profile/bitkraft-ventures) — VC Fund
- [Sam Enrico Williams](https://shizune.co/investors/profile/sam-enrico-williams-d11c) — Angel Investor
- [Courtside Ventures](https://shizune.co/investors/profile/courtside-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund
- [APY Ventures](https://shizune.co/investors/profile/apy-ventures) — VC Fund
- [Boğaziçi Ventures](https://shizune.co/investors/profile/bo%C4%9Fazi%C3%A7i-ventures) — VC Fund

## Featured in investor lists
- [All Investors in Turkey](https://shizune.co/investors/investors-turkey)
- [All VC Funds in Turkey](https://shizune.co/investors/vc-funds-turkey)
- [SaaS Investors in Turkey](https://shizune.co/investors/saas-investors-turkey)
- [SaaS VC Funds in Turkey](https://shizune.co/investors/saas-vc-funds-turkey)
- [Enterprise VC Funds in Turkey](https://shizune.co/investors/enterprise-vc-funds-turkey)
- [Hardware Investors in Turkey](https://shizune.co/investors/hardware-investors-turkey)

## FAQ

### What does ACT Venture Partners invest in?

ACT Venture Partners invests primarily in Software, Artificial Intelligence and Biotechnology startups, most often at Seed and Series A stage. Most of the 42 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is ACT Venture Partners's check size?

ACT Venture Partners typically joins rounds of $345k–$3.2M at Seed, $2.4M–$9.5M at Series A and $987k–$1.3M at Convertible Note. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ACT Venture Partners participates in.

### How do I contact ACT Venture Partners?

Public channels for ACT Venture Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at ACT Venture Partners?

The team at ACT Venture Partners includes Duy Louis Tran (Investment Analyst), Erhan Z. Kilicozlu (Managing Partner) and Gokhan Guner (Managing Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co